Skip to main content

Table 3 Therapeutic approach for thirty-one cSLE patients at the beginning of the study

From: Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus

Total, n = 31 n (%)
Cyclophosphamide 17 (55.0)
Azathioprine 13 (42.0)
Mycophenolate mofetil 13 (42.0)
Rituximab 3 (9.6)
Immunoglobulins 5 (16.0)
Tacrolimus 3 (9.6)
Methotrexate 1 (3.2)
Hydroxychloroquine 31 (100.0)